United Drug PLC UDG Holding(s) in Company

  United Drug PLC (UDG) - Holding(s) in Company

RNS Number : 0320Q
United Drug PLC
31 October 2012








                              Standard Form TR-1
   Voting rights attached to shares- Article 12(1) of directive 2004/109/EC
 Financial instruments - Article 11(3) of the Commission Directive 2007/14/EC

1. Identity of the issuer or the underlying issuer of existing shares
to which voting rights are attached: UNITED DRUG PUBLIC LIMITED COMPANY

2. Reason for the notification (please tick the appropriate box or
boxes):

[ X]  an acquisition or disposal of voting rights

[ ]  an acquisition or disposal of financial instruments which may  result 
in the  acquisition  of shares  already  issued  to which  voting  rights  are 
attached

[ ] an event changing the breakdown of voting rights

3. Full name of person(s) subject to the notification obligation:

 AVIVA PLC AND ITS SUBSIDIARIES

4. Full name of shareholder(s) (if different from 3.):

 REGISTERED HOLDER:

 BNY Norwich Union Nominees
Limited493,849*



 Chase (GA Group) Nominees Ltd   
5,704,142*



 Chase Nominees Limited 
 600,522*



 CUIM Nominee Limited  
133,004*



 *denotes direct interest

5.  Date of the transaction and date on which the threshold is crossed
or reached:

 26 OCTOBER 2012

6. Date on which issuer notified;

 31 OCTOBER 2012

7.  Threshold(s) that is/are crossed or reached:

 3% TO <3% CHANGE AT DIRECT INTEREST LEVEL

8.  Notified details:



A) Voting rights attached to shares
Class/type   Situation previous  Resulting situation after the triggering
of shares    to the Triggering   transaction
(if possible transaction
using the    Number of Number of Number of Number of voting    % of voting
ISIN CODE)   Shares    Voting    shares    rights              rights
                       rights    Direct    Direct    Indirect  Direct Indirect
IE0033024807 7,360,294 7,360,294 6,931,517 6,931,517 Below     2.89%  Below
                                                     Threshold        Threshold



B) Financial Instruments
Resulting situation after the triggering transaction
Type of    Expiration Exercise/Conversion Number of voting rights that % of
financial  Date       Period/ Date         may be acquired if the       voting
instrument                                 instrument is                rights
                                           exercised/converted
                      SUBTOTAL B (in
                      relation to all
                      expiration dates)



Total (A+B) number of voting rights % of voting rights
6,931,517   239,544,133             2.89%



9. Chain of controlled undertakings through which the voting rights
and/or the financial instrumentsare effectively held, if applicable:

The voting rights are managed and controlled by Aviva Investors Global
Services Limited, with the following chain of controlled undertakings:-



Aviva Investors Global Services Limited:

· Aviva plc (Parent Company)

· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

· Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva
Group Holdings Limited)

· Aviva Investors Global Services Limited (wholly owned subsidiary of
Aviva Investors Holdings Limited)



10. In case of proxy voting:[name of the proxy holder] will cease to
hold [number] voting rights as of [date].



11. Additional information:

Figures are based on a total number of voting rights of 239,544,133, as per
the Company's Total Voting Rights Announcement of 1 October 2012.





Annex to the standard form TR-1

a) Identity of the person or legal entity subject to the notification
obligation:

Full name      UNITED DRUG PUBLIC LIMITED COMPANY................................
(including
legal form for
legal
entities)
Contact        UNITED DRUG HOUSE
address
(registered    MAGNA DRIVE
office for
legal          MAGNA BUSINESS PARK
entities)
               CITYWEST ROAD

               DUBLIN 24

               .....................................................................

               .....................................................................
Phone number   ....................................................................
Other useful   …………………………………………….
information
(at least
legal
representative
for legal
persons)

b)  Identity of the notifier, if applicable:

Full name    DIANE THIRKETTLE

             GLOBAL REPORTING UNIT

             AVIVA PLC

             SURREY STREET

             NORWICH

             NR1 3DR

             ....................................................................
Contact      .....................................................................
address
             .....................................................................
Phone number 00 44 1603 687803

             ....................................................................
Other useful 
information
(e.g.
functional
relationship
with the
person or
legal entity
subject to
the
notification
obligation)

c) Additional information

                     This information is provided by RNS
           The company news service from the London Stock Exchange

END


HOLBRBDGRXXBGDB -0- Oct/31/2012 17:38 GMT
 
Press spacebar to pause and continue. Press esc to stop.